CompletedNot Applicable

PRT vs MET in Non-Specific Low Back Pain With Facet Restriction

Palestinian Territories36 participantsStarted 2023-09-02

Plain-language summary

Objective:The study aimed to compare the effectiveness of Positional Release Technique (PRT) and Muscle Energy Technique (MET) in reducing pain and improving outcomes for patients suffering from non-specific low back pain (NSLBP). Materials and Methods: Thirty-six patients between the ages of 25 and 50, all referred by an orthopedic surgeon for treatment of non-specific low back pain (NSLBP), were enrolled in the study. Participants were randomly allocated into two groups (n=18 per group) using a computer-generated randomization sequence. However, details regarding allocation concealment and blinding of participants or assessors were not specified, which may influence the risk of bias. Group A received Positional Release Technique (PRT), while Group B received Muscle Energy Technique (MET). Prior to each treatment session, both groups received a standardized 15-minute hot pack application as a co-intervention to promote muscle relaxation and ensure consistency across interventions. Pain intensity was assessed using the Visual Analogue Scale (VAS), and functional outcomes were measured with the Roland-Morris Disability Questionnaire (RMQ). Participants in both groups attended three physiotherapy sessions per week over a four-week treatment period.

Who can participate

Age range

25 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Participants in the age category of 25 to 50 years old. * both male and female, with a diagnosis of low back pain (LBP), with or without referred leg pain. * chronic LBP lasting more than three months. Exclusion criteria: * Osteoporosis. * bone disease. * Spondylolisthesis. * History of vertebral fracture. * History of spinal surgery.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

VAS - Baseline and after 4 weeks. Functional disability (Roland-Morris Questionnaire, RMQ) - Baseline and after 4 weeks.

Timeframe: 4 weeks

RMQ

Timeframe: 4 weeks

Trial details

NCT IDNCT07165249

SponsorPalestine Ahliya University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-15

View on ClinicalTrials.gov More Non Specific Low Back Pain trials